申请人:Pfizer Inc.
公开号:US04491583A1
公开(公告)日:1985-01-01
A process for inducing the production of endogenous interferon in a vertebrate animal which comprises parenterally, intranasally or topically adminstering to the animal an interferon-inducing effective amount of composition containing as the essential active ingredient a compound of the formula ##STR1## or a non-toxic acid addition salt thereof wherein R.sub.7 and R.sub.8 are each alkyl of from 12 to 30 carbon atoms and Z is selected from the group consisting of N-(lower alkyl)-piperazino and N-(W-hydroxy-lower alkyl)-piperazino, said lower alkyl groups having from 1 to 4 carbon atoms.
一种诱导脊椎动物内源性干扰素产生的过程,包括将含有以下式子中化合物或其非毒性酸加成盐的本质活性成分的诱导干扰素的有效量的组合物通过肌肉注射、鼻内或局部给药于动物,其中R.sub.7和R.sub.8分别是12至30个碳原子的烷基,Z选自N-(低烷基)-哌嗪和N-(W-羟基-低烷基)-哌嗪的群,所述低烷基基团具有1至4个碳原子。